Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong
· Delayed Price · Currency is HKD 0.189
0.00 (0.00%)
Apr 28, 2026, 2:20 PM HKT
HKG:6833 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,085 | 2,821 | 2,540 | 2,272 | 2,024 | Upgrade
|
| Revenue Growth (YoY) | -26.11% | 11.07% | 11.82% | 12.22% | -1.26% | Upgrade
|
| Cost of Revenue | 1,862 | 2,521 | 2,217 | 1,966 | 1,659 | Upgrade
|
| Gross Profit | 222.09 | 299.94 | 323.28 | 305.87 | 364.95 | Upgrade
|
| Selling, General & Admin | 140.32 | 189.92 | 202.58 | 198.44 | 171.38 | Upgrade
|
| Operating Expenses | 147.42 | 186 | 206.82 | 204.64 | 172.4 | Upgrade
|
| Operating Income | 74.68 | 113.95 | 116.46 | 101.22 | 192.55 | Upgrade
|
| Interest Expense | -15.37 | -12.55 | -9.81 | -13.81 | -21.45 | Upgrade
|
| Interest & Investment Income | 4.02 | 6.12 | 5.97 | 2.42 | 1.31 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.15 | -12.6 | -8.64 | 15.98 | -3.55 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.92 | 8.93 | -1.13 | -3.89 | -1.49 | Upgrade
|
| EBT Excluding Unusual Items | 48.26 | 103.84 | 102.85 | 101.93 | 167.39 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.04 | - | - | Upgrade
|
| Other Unusual Items | - | -4.92 | -3 | -2.63 | - | Upgrade
|
| Pretax Income | 48.26 | 98.92 | 99.88 | 99.29 | 167.39 | Upgrade
|
| Income Tax Expense | 13.41 | 56.88 | 57.53 | 29.83 | 32.3 | Upgrade
|
| Earnings From Continuing Operations | 34.85 | 42.05 | 42.35 | 69.46 | 135.08 | Upgrade
|
| Net Income | 34.85 | 42.05 | 42.35 | 69.46 | 135.08 | Upgrade
|
| Net Income to Common | 34.85 | 42.05 | 42.35 | 69.46 | 135.08 | Upgrade
|
| Net Income Growth | -17.11% | -0.73% | -39.03% | -48.58% | 14.34% | Upgrade
|
| Shares Outstanding (Basic) | 2,033 | 2,033 | 2,033 | 2,032 | 1,737 | Upgrade
|
| Shares Outstanding (Diluted) | 2,033 | 2,033 | 2,033 | 2,032 | 1,737 | Upgrade
|
| Shares Change (YoY) | - | - | 0.07% | 16.93% | 2.69% | Upgrade
|
| EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.03 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.03 | 0.08 | Upgrade
|
| EPS Growth | -15.00% | - | -41.18% | -56.28% | 11.39% | Upgrade
|
| Free Cash Flow | 197.55 | -268.04 | 324.15 | 22.39 | 282.19 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | -0.13 | 0.16 | 0.01 | 0.16 | Upgrade
|
| Dividend Per Share | 0.002 | 0.002 | 0.004 | 0.009 | - | Upgrade
|
| Dividend Growth | -16.50% | -43.50% | -59.16% | - | - | Upgrade
|
| Gross Margin | 10.65% | 10.63% | 12.73% | 13.46% | 18.03% | Upgrade
|
| Operating Margin | 3.58% | 4.04% | 4.58% | 4.46% | 9.51% | Upgrade
|
| Profit Margin | 1.67% | 1.49% | 1.67% | 3.06% | 6.67% | Upgrade
|
| Free Cash Flow Margin | 9.48% | -9.50% | 12.76% | 0.99% | 13.94% | Upgrade
|
| EBITDA | 93.45 | 132.52 | 127.34 | 109.01 | 197.69 | Upgrade
|
| EBITDA Margin | 4.48% | 4.70% | 5.01% | 4.80% | 9.77% | Upgrade
|
| D&A For EBITDA | 18.78 | 18.58 | 10.88 | 7.79 | 5.14 | Upgrade
|
| EBIT | 74.68 | 113.95 | 116.46 | 101.22 | 192.55 | Upgrade
|
| EBIT Margin | 3.58% | 4.04% | 4.58% | 4.46% | 9.51% | Upgrade
|
| Effective Tax Rate | 27.78% | 57.50% | 57.60% | 30.04% | 19.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.